06.01.2015 Views

Child Poverty in Mozambique. A Situation and Trend ... - Unicef

Child Poverty in Mozambique. A Situation and Trend ... - Unicef

Child Poverty in Mozambique. A Situation and Trend ... - Unicef

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Table 3.3: Overview of PMTCT programme performance between 2002 <strong>and</strong> 2006<br />

Total Pregnant Total HIV+ HIV+ Babies who<br />

pregnant women pregnant pregnant women who received<br />

women counselled women women who delivered <strong>in</strong> ARV<br />

attend<strong>in</strong>g <strong>and</strong> tested HIV+ received a health prophylaxis<br />

ANC ARV facility<br />

prophylaxis<br />

2002 5,685 4,641 951 253 391 328<br />

2003 27,437 24,260 4,273 877 1,428 1,490<br />

2004 65,562 46,583 6,576 3,182 3,002 3,335<br />

2005 158,273 102,116 14,193 7,690 5,754 5,439<br />

2006* 94,916 72,308 10,319 8,728 8,855 5,500<br />

Total 351,873 249,908 36,312 20,730 19,430 16,092<br />

Source: MISAU, 2006<br />

* Data for 2006 are from January to June only<br />

Between the start of the national programme <strong>in</strong> 2002 <strong>and</strong> mid-2006, about 54 per<br />

cent of the pregnant women that tested HIV positive delivered <strong>in</strong> a health facility<br />

<strong>and</strong> 57 per cent received ARV prophylaxis, while 44 per cent of their <strong>in</strong>fants received<br />

it. The uptake of Nevirap<strong>in</strong>e is improv<strong>in</strong>g, from 27 per cent <strong>in</strong> 2002 to 85 per cent<br />

at mid year <strong>in</strong> 2006. The proportion of children who received Nevirap<strong>in</strong>e <strong>in</strong> PMTCT<br />

programmes <strong>and</strong> who were subsequently tested at 18 months is only around 8 per<br />

cent. Of those, 89 per cent tested negative <strong>and</strong> 11 per cent tested positive. The<br />

status of the vast majority of the children who received PMTCT services is unknown,<br />

as the children are lost to follow-up dur<strong>in</strong>g the 18 months before the HIV antibody<br />

test becomes possible.<br />

One of the most important factors associated with <strong>in</strong>creased risk of mother to child<br />

transmission is the mode <strong>and</strong> duration of breastfeed<strong>in</strong>g, together with vag<strong>in</strong>al delivery<br />

<strong>and</strong> maternal HIV viral load (Lancet, 2006 Feb; Vol 6: 83-90). No data is yet available<br />

<strong>in</strong> <strong>Mozambique</strong> concern<strong>in</strong>g the percentage of HIV positive mothers who choose<br />

replacement feed<strong>in</strong>g over breast milk, or at what po<strong>in</strong>t these mothers stop breast<br />

feed<strong>in</strong>g. Accord<strong>in</strong>g to health worker reports, however, the vast majority of mothers<br />

follow the usual tradition <strong>and</strong> breastfeed until a child is 18-24 months old, albeit with<br />

early cessation of exclusive breastfeed<strong>in</strong>g. Prelim<strong>in</strong>ary results of an evaluation of<br />

Early Breastfeed<strong>in</strong>g Cessation <strong>and</strong> Replacement Feed<strong>in</strong>g conducted <strong>in</strong> 2005 by the<br />

Elizabeth Glazer Paediatric AIDS Foundation <strong>and</strong> Health Alliance International <strong>in</strong> three<br />

prov<strong>in</strong>ces of <strong>Mozambique</strong> <strong>in</strong>dicated that the majority of mothers did not have the<br />

means to provide an adequate replacement diet for their babies.<br />

Prioritis<strong>in</strong>g access to Highly Active ARV Therapy (HAART) by pregnant women is<br />

critical, given the very high risk of post-natal transmission <strong>in</strong> breastfeed<strong>in</strong>g mothers<br />

with low CD4 <strong>and</strong> high viral load <strong>and</strong> <strong>in</strong> the context of the challenges faced by<br />

mothers <strong>in</strong> implement<strong>in</strong>g recommended <strong>in</strong>fant feed<strong>in</strong>g options. Women with<br />

CD4 counts less than 200 cells/µl are 5 times more likely to transmit HIV dur<strong>in</strong>g<br />

breastfeed<strong>in</strong>g as compared with CD4 counts over 500 cells/ µl (Iliff, 2005). HAART can<br />

further reduce the risk of transmission to approximately 2 per cent, as compared to<br />

the more widespread <strong>in</strong>terventions currently used, e.g. s<strong>in</strong>gle dose Nevirap<strong>in</strong>e (10-15<br />

per cent). Currently, the M<strong>in</strong>istry of Health policy is that pregnant women with CD4<br />

counts of under 350 are eligible for HAART, as opposed to the st<strong>and</strong>ard adult criteria<br />

of under 200. However, very few pregnant women are enrolled <strong>in</strong> treatment centres.<br />

In 2005, about 550 pregnant HIV-positive women were enrolled on HAART (out of<br />

a total of about 20,000 people on HAART <strong>and</strong> over 14,000 HIV positive pregnant<br />

women tested <strong>in</strong> PMTCT sites). Increas<strong>in</strong>g enrolment of pregnant <strong>and</strong> lactat<strong>in</strong>g<br />

women requires close coord<strong>in</strong>ation between PMTCT programmes <strong>and</strong> ARV treatment<br />

sites <strong>and</strong> the <strong>in</strong>itiation of HAART with<strong>in</strong> PMTCT programmes.<br />

108 CHILDHOOD POVERTY IN MOZAMBIQUE: A SITUATION AND TRENDS ANALYSIS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!